
Recurrent pregnancy loss (RPL) is defined as three or more consecutive pregnancy losses, and it affects 2-3% of couples trying to conceive. RPL is a multifactorial disorder, and only few evidence-based treatments are available. It is associated with an increased prevalence of stress and major depression, and also with immunogenetic markers, autoimmunity and an increase of the risk of cardiovascular disease in later life. Immunology seems to be a key element in RPL, and further research is needed to understand the pathogenesis of this heterogeneous condition in order to develop personalized treatment.
Abortion, Habitual, HLA-A Antigens, Pregnancy, Risk Factors, Histocompatibility Antigens Class II, Humans, Th17 Cells, Female, T-Lymphocytes, Regulatory, Biomarkers, HLA-DRB1 Chains
Abortion, Habitual, HLA-A Antigens, Pregnancy, Risk Factors, Histocompatibility Antigens Class II, Humans, Th17 Cells, Female, T-Lymphocytes, Regulatory, Biomarkers, HLA-DRB1 Chains
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
